Home  /  Insights  /  Market Access

You can have the right drug and still lose at the pharmacy.

In specialty markets, the days between a written prescription and a first fill decide whether therapy starts. That handoff is a channel design decision, not a vendor issue.

A prescription is not a patient on therapy. In specialty markets it is the start of a handoff that can run for days or weeks, across a specialty pharmacy, a benefits check, a prior authorization and a phone call the patient may not answer. Every step is handled by someone competent. Nobody is measured on the whole.

When the handoff works, nobody notices it. When it does not, the brand reads it as soft demand, the field hears it as frustrated offices, and Finance sees it a quarter later as a volume shortfall with no cause attached.

What happens after the prescription leaves the office

The prescription goes to a specialty pharmacy that the office chose, the payer requires, or the brand’s network designates. From there the clock starts. Benefits are verified, a prior authorization is submitted if one is needed, the patient’s cost is calculated, and someone has to reach the patient to confirm, consent and schedule delivery. Only then does the pharmacy dispense.

Each step has its own queue. The patient sees one thing: a treatment they were told about that has not arrived.

Where prescriptions stall

  • Specialty pharmacy triage.The prescription lands at a pharmacy outside the patient’s plan network or the brand’s network and has to be transferred. Each transfer restarts part of the clock.
  • Benefits verification.Coverage is checked, rechecked and sometimes wrong. A medical versus pharmacy benefit question can hold a prescription for days on its own.
  • Limited network routing.A narrow network protects service quality and data, but only when the routing rules are clear to offices, payers and patients. When they are not, prescriptions wander.
  • Patient contact and consent.The pharmacy calls from a number the patient does not recognize. Two missed calls later, the prescription is closed as abandoned.
Written is not filledAn illustrative timeline from a written prescription to a first fill, with the handoffs in between and the places where prescriptions typically stall.WrittenRouted to specialty pharmacyBenefits verifiedPrior authorization clearedPatient reached and consentedFirst fillTransfer between pharmaciesBenefit type unclearRequest pending or deniedMissed calls, case closedEach handoff has its own queue. The patient sees only the wait.
Written is not filled. Illustrative only: each handoff between the office and the first fill is a place where a prescription waits, and some never leave.

Time to therapy is the number Finance never sees

Most organizations track prescriptions written and units shipped. The time between them, and the share of prescriptions that never become a first fill, usually sits in a specialty pharmacy data feed that Commercial reads and Finance does not.

That is the gap. Time to therapy is a leading indicator. A slower handoff this month becomes a lower persistence curve next quarter, affordability spend on patients who started late, and a demand forecast that assumed every written prescription became a patient.

Four channel choices that set the outcome

  • Open or limited network.How many specialty pharmacies can dispense, and who decides where a prescription goes.
  • Data agreements.What each pharmacy reports, at what level of detail, and how fast. Without status-level data, stalls stay invisible until they become abandonment.
  • Service and dispensing fees.What the brand pays for, and whether the fee structure rewards speed to first fill or only volume.
  • Patient hub handoffs.Who owns the patient between the office and the pharmacy, and whether a case moves between the patient hub and the pharmacy without starting over.

Where it lands in Gross-to-Net

Every one of these choices has a line in the Gross-to-Net waterfall. Network design sets service and data fees. Handoff speed sets how much bridge supply and copay support is spent before a patient is stable. Abandonment removes volume the forecast counted, which spreads fixed channel costs across fewer patients.

Three measures, reviewed weekly, catch most of it before it reaches the number:

  • Days to first fill.From written to first fill, by pharmacy and by payer.
  • Prescriptions that never fill.The share that never reach a first fill, and the step where each one stopped.
  • Transfers per prescription.Each one is a handoff that did not have to happen.

The right drug earns the prescription. The channel decides whether the patient ever receives it.